How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report.

Antonello Sica Caterina SagnelliBeniamino CasaleGino SvaneraMassimiliano CretaArmando CalogeroRenato FrancoEvangelista SagnelliAndrea Ronchi

Published in: Healthcare (Basel, Switzerland) (2021)

The response to crizotinib was optimal since no adverse event occurred, and CT-PET scans persisted negative; this drug has proved to be a valid bridge to allo-SCT.

Keyphrases

computed tomography
coronavirus disease
positron emission tomography
sars cov
advanced non small cell lung cancer
dual energy
contrast enhanced
single cell
cell therapy
image quality
adverse drug
stem cells
pet imaging
bone marrow
replacement therapy
magnetic resonance
mesenchymal stem cells